|
PRESS RELEASES
RAYMEDICA® RELEASES VOLUMES II & III
OF THE 4-VOLUME SERIES ON "NUCLEUS ARTHROPLASTY™ TECHNOLOGY
IN SPINAL CARE"
MINNEAPOLIS - April 30, 2007 - Raymedica,
the Pioneer in Nucleus Arthroplasty, announced today that Volume II,
Biomechanics & Development and Volume III, Surgical Techniques &
Technologies in the ground-breaking 4-Volume Series entitled, “Nucleus
Arthroplasty™ Technology in Spinal Care” will be released
at the Spine Arthroplasty Society 7th (SAS7) Annual Conference being
held in Berlin, Germany, May 1-4, 2007. The complimentary publications
will be made available at Raymedica Booth # 21.
Raymedica has jointly produced and published Volumes II & III of
the 4-Volume series entitled, “Nucleus Arthroplasty Technology
in Spinal Care” with the Deputy Review Board of Reginald J. Davis,
MD, FACS; Federico P. Girardi, MD; Frank P. Cammisa, Jr. MD, FACS and
William C. Hutton, DSc. Their constructive and creative guidance in
the selection of relevant materials will influence nucleus arthroplasty
technology and its impact on non-fusion spine surgery.
“The series is a great resource because it allows the individual
to read and download copies about Nucleus Arthroplasty Technology from
respected and esteemed group of authors.” stated John J. Viscogliosi,
Chairman and Chief Executive Officer of Raymedica, LLC.
“We are reaching innovators and early adopters who are actively
searching for better ways to meet their patient needs.” Mr. Viscogliosi
continued, “The series is a natural resource for educational information
designed to provide valuable guidance to spine surgeons as they seek
to provide more effective and less invasive options for the treatment
of degenerative disc disease (DDD).”
About Raymedica
Raymedica, based in Minneapolis, Minnesota, is the Pioneer in Nucleus
Arthroplasty having developed the world’s first nucleus replacement
device in 1996. Raymedica develops, manufactures and markets medical
device systems designed to treat patients with degenerative disc disease
that have been unresponsive to non-surgical treatment. Raymedica’s
products are currently available in many countries worldwide, but are
limited to investigational use only in the United States. For more information,
visit the Company's website at http://www.raymedica.com.
About
Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony
G. Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB)
was the first venture capital/private equity and merchant banking firm
dedicated to the musculoskeletal/orthopedics sector of the health care
industry.
Today, VB is a leading independent firm with a mission to create, build
and finance companies founded on innovations developed by surgeons and
uniquely focused on "life changing" musculoskeletal/orthopedic
technologies. VB has worldwide surgeon, industry and trade relationships
and significant financial expertise in the musculoskeletal/orthopedic
sector.
As principals of VB, the Viscogliosi brothers have a combined total
of nearly half a century of experience analyzing and investing in the
musculoskeletal/orthopedics sector, directing literally billions of
dollars through the orthopedics industry. They have pioneered
innovative financial, strategic and management initiatives for nearly
150 companies in the sector, from start-up, seed and development stage
all the way to exit, while helping thousands of people lead better lives
through the orthopedic and spinal products marketed and sold by the
companies they have assisted in developing and financing.
> Back to Press Releases
|
